SpringerLink
Log in

New antibacterial microporous CaP materials loaded with phages for prophylactic treatment in bone surgery

  • Published:
Journal of Materials Science: Materials in Medicine Aims and scope Submit manuscript

Abstract

Hydroxyapatite and beta-tricalcium phosphate (β-TCP) are materials commonly used in bone repair. The most important problem occurring in bone repair surgery is bacterial infection which is usually overcome by treatment with antibiotics. Currently, emergence of multidrug resistant strains has led to development of alternative treatments such as phage therapy. Phages are bacterial viruses with several advantages over chemotherapy such as specificity of bacterial strain, no side effects and fast response. This study evaluates the possibility of loading hydroxyapatite and β-tricalcium phosphate ceramics used as bone substitutes with phages and their antibacterial activity against Escherichia coli K12. The majority of phages were retained in dense and microporous HA and β-TCP samples during at least 6 days suggesting the occurrence of strong interaction between phages and ceramics, which did not prevent bacterial attachment and lysis. This study has shown for the first time that phage loaded ceramics could be used in prophylactic treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Bratzler DW, Houck PM, Surgical Infection Prevention Guidelines Writers Workgroup, American Academy of Orthopaedic Surgeons, American Association of Critical Care Nurses, American Association of Nurse Anesthetists, American College of Surgeons, American College of Osteopathic Surgeons, American Geriatrics Society, American Society of Anesthesiologists, American Society of Colon and Rectal Surgeons, American Society of Health-System Pharmacists, American Society of PeriAnesthesia Nurses, Ascension Health, Association of periOperative Registered Nurses, Association for Professionals in Infection Control and Epidemiology, Infectious Diseases Society of America, Medical Letter, Premier, Society for Healthcare Epidemiology of America, Society of Thoracic Surgeons, Surgical Infection Society. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004;38(12):1706–15.

    Article  Google Scholar 

  2. van de Belt H, Neut D, Schenk W, van Horn JR, van der Mei HC, Busscher HJ. Infection of orthopedic implants and the use of antibiotic-loaded bone cements. A review Acta Orthop Scand. 2001;72(6):557–71.

    Article  Google Scholar 

  3. Viguier E, Bignon A, Laurent F, Goehrig D, Boivin G, Chevalier J. J A new concept of gentamicine loaded HAP/TCP bone substitute for prophylactic action: in vivo pharmacokinetic study. Mater Sci Mater Med. 2011;22(4):879.

    Article  CAS  Google Scholar 

  4. Randelli P, Evola FR, Cabitza P, Polli L, Denti M, Vaienti L. Knee, prophylactic use of antibiotic-loaded bone cement in primary total knee replacement. Surg Sports Traumatol Arthrosc. 2010;18(2):181–6.

    Article  Google Scholar 

  5. Wu P, Grainger DW. Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials. 2006;27(11):2450–67.

    Article  CAS  Google Scholar 

  6. Simchi A, Tamjid E, Pishbin F, Boccaccini AR. Recent progress in inorganic and composite coatings with bactericidal capability for orthopaedic applications. Nanomedicine. 2011;7(1):22–39.

    Article  CAS  Google Scholar 

  7. Hornez JC, Chai F, Monchau F, Blanchemain N, Descamps M, Hildebrand HF. Biological and physico-chemical assessment of hydroxyapatite (HA) with different porosity. Biomol Eng. 2007;24(5):505–9.

    Article  CAS  Google Scholar 

  8. Rauschmann MA, Wichelhaus TA, Stirnal V, Dingeldein E, Zichner L, Schnettler R, Alt V. Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. Biomaterials. 2005;26(15):2677–84.

    Article  CAS  Google Scholar 

  9. Chai F, Hornez JC, Blanchemain N, Neut C, Descamps M, Hildebrand HF. Antibacterial activation of hydroxyapatite (HA) with controlled porosity by different antibiotics. Biomol Eng. 2007;24(5):510–4.

    Article  CAS  Google Scholar 

  10. Barrow PA, Soothill JS. Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential. Trends Microbiol. 1997;5(7):268–71.

    Article  CAS  Google Scholar 

  11. Merril CR, Scholl D, Adhya SL. The prospect for bacteriophage therapy in Western medicine. Nat Rev Drug Discov. 2003;2:489–97.

    Article  CAS  Google Scholar 

  12. Kutateladze M, Adamia R. Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol. 2010;28(12):591–5.

    Article  CAS  Google Scholar 

  13. Pirnay JP, De Vos D, Verbeken G, Merabishvili M, Chanishvili N, Vaneechoutte M, Zizi M, Laire G, Lavigne R, Huys I, Van den Mooter G, Buckling A, Debarbieux L, Pouillot F, Azeredo J, Kutter E, Dublanchet A, Górski A, Adamia R. The phage therapy paradigm: prêt-à-porter or sur-mesure? Pharm Res. 2011;28(4):934–7.

    Article  CAS  Google Scholar 

  14. Skurnik K, Strauch E. Phage therapy: facts and fiction Int J. Med Microbiol. 2006;296:5–14.

    CAS  Google Scholar 

  15. Hung CH, Kuo CF, Wang CH, Wu CM, Tsao N. Experimental phage therapy in treating Klebsiella pneumoniae-mediated liver abscesses and bacteremia in mice. Antimicrob Agents Chemother. 2011;55(4):1358–65.

    Article  CAS  Google Scholar 

  16. Sunagar R, Patil SA, Chandrakanth RK. Bacteriophage therapy for Staphylococcus aureus bacteremia in streptozotocin-induced diabetic mice. Res Microbiol. 2010;161(10):854–60.

    Article  Google Scholar 

  17. Jacob F, Wollman EL. Induction spontanée du développement du bactériophage λ au cours de la recombinaison génétique, chez E. coli K-12. Compt Rend Acad Sci Paris. 1954;239:317–9.

    CAS  Google Scholar 

  18. Isaac J, Hornez JC, Jian D, Descamps M, Hardouin P, Magne D. beta-TCP microporosity decreases the viability and osteoblast differentiation of human bone marrow stromal cells. J Biomed Mater Res A. 2008;86(2):386–93.

    Google Scholar 

  19. Signer ER. A plaque assay for lambda attachment. Virology. 1967;33:352–4.

    Article  CAS  Google Scholar 

  20. Smith GP, Gingrich TR. Hydroxyapatite chromatography of phage-display virions. Biotechniques. 2005;39:879–84.

    Article  CAS  Google Scholar 

  21. Biedenbach DJ, Jones RN. Disk diffusion test interpretive criteria and quality control recommendations for testing linezolid (U-100776) and eperezolid (U-100592) with commercially prepared reagents. J Clin Microbiol. 1997;35:3198–202.

    CAS  Google Scholar 

  22. Hendrix R. Bacteriophage λ and its relatives. In: Streips U, Yasbin R, editors. Modern Microbial Genetics. 2nd ed. Liss: Wiley; 2002.

    Google Scholar 

  23. Bernardi G. Chromatography of proteins on hydroxyapatite. Methods Enzymol. 1973;27:471–9.

    Article  CAS  Google Scholar 

  24. Kim HW, Knowles JC, Kim HE. Development of hydroxyapatite bone scaffold for controlled drug release via poly(epsilon-caprolactone) and hydroxyapatite hybrid coatings. J Biomed Mater Res B Appl Biomater. 2004;70(2):240–9.

    Article  Google Scholar 

  25. Bohner M, Lemaître J, Van Landuyt P, Zambelli PY, Merkle HP, Gander B. Gentamicine-loaded hydraulic calcium phosphate bone cement as antibiotic delivery system. J Pharm Sci. 1997;86(5):565–72.

    Article  CAS  Google Scholar 

  26. Van de Belt H, Neut D, Uges DR, Schenk W, van Horn JR, van der Mei HC, Busscher HJ. Surface roughness, porosity and wettability of gentamicine-loaded bone cements and their antibiotic release. Biomaterials. 2000;21(19):1981–7.

    Article  Google Scholar 

  27. Gupta R, Prasad Y. Efficacy of polyvalent bacteriophage P-27/HP to control multidrug resistant Staphylococcus aureus associated with human infections. Curr Microbiol. 2011;62(1):255–60.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. LMCPA -Université de Valenciennes et du Hainaut-Cambrésis, EA 2443, ZI du Champ de l’Abbesse, Maubeuge, France

    Edwige Meurice, Emmanuelle Rguiti, Annie Brutel, Jean-christophe Hornez, Anne Leriche, Michel Descamps & Franck Bouchart

Authors
  1. Edwige Meurice
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emmanuelle Rguiti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Annie Brutel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jean-christophe Hornez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anne Leriche
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Michel Descamps
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Franck Bouchart
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anne Leriche.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meurice, E., Rguiti, E., Brutel, A. et al. New antibacterial microporous CaP materials loaded with phages for prophylactic treatment in bone surgery. J Mater Sci: Mater Med 23, 2445–2452 (2012). https://doi.org/10.1007/s10856-012-4711-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10856-012-4711-6

Keywords

Search

Navigation